Market Place
Sourcing Support
Chemdiv Extends Partnership With Mondego Bio On PTPN2 Program
24 Oct 2025 //
PR NEWSWIRE
Eilean Therapeutics Present Brain-Permeable CDK2 Inhibitor
16 Oct 2025 //
PR NEWSWIRE
Eilean Present Pan-EGFR Inhibitor ZE77-0273 For EGFR-Mutant NSCLC
13 Oct 2025 //
PR NEWSWIRE
Lomond Therapeutics Report Results for Lonitoclax, BCL-2 Inhibitor
09 Dec 2024 //
PR NEWSWIRE
Lomond Therapeutics Announces FDA Clearance For Lonitoclax Study
15 Oct 2024 //
PR NEWSWIRE
Eilean Thera Receives Clearance to Initiate R/r Aml Trial with Lomonitinib
04 Apr 2024 //
PR NEWSWIRE
Expert Systems Expands Partnership with Eilean Therapeutics
12 Mar 2024 //
PR NEWSWIRE
Eilean Therapeutics Approved To Initiate First Patient Trial With Balamenib
11 Mar 2024 //
PR NEWSWIRE
Eilean Initiates Multiple Dosing Of Healthy Volunteers With Lomonitinib
29 Jan 2024 //
PR NEWSWIRE
Eilean Initiates First In Human Trial With Eiletoclax
29 Jan 2024 //
PR NEWSWIRE
Eilean Therapeutics Doses First Patient With Ze46-0134
21 Aug 2023 //
PR NEWSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.